Proof of Principle Trial to Determine if Nutritional Supplement Conjugated Linoleic Acid (CLA) Can Modulate the Lipogenic Pathway in Breast Cancer Tissue

NCT00908791 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Conjugated Linoleic Acid (CLA)

Sponsor

Dartmouth-Hitchcock Medical Center

Collaborators

[object Object]